ArticleCellular oncology (Dordrecht, Netherlands)2021

Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells.

Joana G Rodrigues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.